Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  46.48 03:01 PM EST  
    Day High 47.23 09:56 AM EST
    Range 0.75  
    Volume 882,489  
    30-Day Avg Vol 1.01 M
    Difference -13.23%  
    Market Cap 7.55 B  
    Mkt Cap Chg -92.43 M  
    Shares Out 162.15 M  
    % Shrs Traded 0.54%  
    1yr EPS Est 3.088  
    52-Wk Low 21.21
    52-Wk High 48.23
    Range 27.02  
    Prev Close 47.16 11/5/09  
    Today's Open 47.17  
    Change 0.02%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 2.36 M

    Performance Details

    Revenue (LFY) 3.62 B  
    Earnings (LFY) 320.90 M  
    Earnings (MRQ) 116.20 M  
    Next Earn Est 0.706  
    Next Earnings 02/15/2010
    EPS (TTM) 2.54  
    1yr EPS Growth 2.59%  
    P/E Ratio (TTM) 18.34  
    P/E Ratio (Fwd) 15.00  
    PEG Ratio 1.21  
    Return on Equity 18.06  
    Beta 0.86  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: HSP

    Blogs are not currently available for hsp.

    View all blogs at BloggingStocks.

  • Related Information: HSP

    Company Overview: HSP

    Hospira helps hospitals help the hurting. The company, a spinoff of drug manufacturer Abbott Laboratories, makes specialty injectable pharmaceuticals (primarily generics) and drug delivery equipment. Its ... View Full Description

    Earnings Analysis: HSP

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.706 2/15/10
    Last Quarter 0.685 9/30/09 0.90 9/30/09 0.215
    Beat
    2 Quarters Ago 0.602 6/30/09 0.73 6/30/09 0.128
    Beat

    Financials: HSP

      Quarterly - 09/30/2009 Annual - 2008
    Total Revenue 1.01 B 3.63 B
    Gross Profit 386.30 M 1.34 B
    Operating Income 184.40 M 531.90 M
    Net Income 116.20 M 320.90 M